Following Drug Uptake and Reactions inside Escherichia coli Cells by Raman Microspectroscopy

Raman microspectroscopy combined with Raman difference spectroscopy reveals the details of chemical reactions within bacterial cells. The method provides direct quantitative data on penetration of druglike molecules into Escherichia coli cells in situ along with the details of drug–target reactions. With this label-free technique, clavulanic acid and tazobactam can be observed as they penetrate into E. coli cells and subsequently inhibit β-lactamase enzymes produced within these cells. When E. coli cells contain a β-lactamase that forms a stable complex with an inhibitor, the Raman signature of the known enamine acyl–enzyme complex is detected. From Raman intensities it is facile to measure semiquantitatively the number of clavulanic acid molecules taken up by the lactamase-free cells during growth.

[1]  E. J. de la Rosa,et al.  Penicillin binding proteins: role in initiation of murein synthesis in Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Bonomo,et al.  Raman spectra of interchanging β-lactamase inhibitor intermediates on the millisecond time scale. , 2013, Journal of the American Chemical Society.

[3]  K. Lewis.  Platforms for antibiotic discovery , 2013, Nature Reviews Drug Discovery.

[4]  R. Bonomo,et al.  Clavulanic acid inactivation of SHV-1 and the inhibitor-resistant S130G SHV-1 beta-lactamase. Insights into the mechanism of inhibition. , 2004, The Journal of biological chemistry.

[5]  P. Bradford.  Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat , 2001, Clinical Microbiology Reviews.

[6]  P. Carey,et al.  Kinetic crystallography by Raman microscopy. , 2011, Biochimica et biophysica acta.

[7]  S. Lane,et al.  Effect of cefazolin treatment on the nonresonant Raman signatures of the metabolic state of individual Escherichia coli cells. , 2010, Analytical chemistry.

[8]  R. Bonomo,et al.  Mutagenesis of amino acid residues in the SHV-1 beta-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance. , 2001, Biochimica et biophysica acta.

[9]  Hiro-o Hamaguchi,et al.  Molecular‐level pursuit of yeast mitosis by time‐ and space‐resolved Raman spectroscopy , 2003 .

[10]  R. Bonomo,et al.  Inhibitor Resistance in the KPC-2 β-Lactamase, a Preeminent Property of This Class A β-Lactamase , 2009, Antimicrobial Agents and Chemotherapy.

[11]  H. Hamaguchi,et al.  Casting new physicochemical light on the fundamental biological processes in single living cells by using Raman microspectroscopy. , 2012, Chemical record.

[12]  R. Callender,et al.  Nonresonance Raman difference spectroscopy: a general probe of protein structure, ligand binding, enzymatic catalysis, and the structures of other biomacromolecules. , 1994, Annual review of biophysics and biomolecular structure.

[13]  R. Bonomo,et al.  Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography. , 2003, Biochemistry.

[14]  D. Rousseau.  Raman difference spectroscopy as a probe of biological molecules , 1981 .

[15]  P. Carey,et al.  Raman crystallography and other biochemical applications of Raman microscopy. , 2006, Annual review of physical chemistry.

[16]  J. Greve,et al.  Studying single living cells and chromosomes by confocal Raman microspectroscopy , 1990, Nature.

[17]  R. Bonomo,et al.  Substrate Selectivity and a Novel Role in Inhibitor Discrimination by Residue 237 in the KPC-2 β-Lactamase , 2010, Antimicrobial Agents and Chemotherapy.

[18]  Paul R. Carey,et al.  Biochemical Applications of Raman and Resonance Raman Spectroscopies , 1982 .

[19]  R. Bonomo,et al.  High Resolution Crystal Structures of the trans-Enamine Intermediates Formed by Sulbactam and Clavulanic Acid and E166A SHV-1 β-Lactamase* , 2005, Journal of Biological Chemistry.

[20]  W. R. Premasiri,et al.  On the Difference between Surface-Enhanced Raman Scattering (SERS) Spectra of Cell Growth Media and Whole Bacterial Cells , 2011, Applied spectroscopy.

[21]  V. Bloomfield,et al.  Dependence of the Raman signature of genomic B-DNA on nucleotide base sequence. , 1999, Biopolymers.

[22]  R. Bonomo,et al.  Three Decades of β-Lactamase Inhibitors , 2010, Clinical Microbiology Reviews.

[23]  J. Williams,et al.  Antibacterial characteristics of YTR 830, a sulfone beta-lactamase inhibitor, compared with those of clavulanic acid and sulbactam , 1988, Antimicrobial Agents and Chemotherapy.

[24]  J. Popp,et al.  Identification of Bacillus anthracis via Raman spectroscopy and chemometric approaches. , 2012, Analytical chemistry.

[25]  P. D. de Boer,et al.  Targeting of DMinC/MinD and DMinC/DicB Complexes to Septal Rings in Escherichia coli Suggests a Multistep Mechanism for MinC-Mediated Destruction of Nascent FtsZ Rings , 2002, Journal of bacteriology.

[26]  D. Payne,et al.  Penetration of β-lactamase inhibitors into the periplasm of Gram-negative bacteria , 1999 .

[27]  B. Spratt.  Distinct penicillin binding proteins involved in the division, elongation, and shape of Escherichia coli K12. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[28]  F. Yoshimura,et al.  Diffusion of beta-lactam antibiotics through the porin channels of Escherichia coli K-12 , 1985, Antimicrobial Agents and Chemotherapy.

[29]  J. Frère,et al.  Method for Estimation of Low Outer Membrane Permeability to β-Lactam Antibiotics , 2002, Antimicrobial Agents and Chemotherapy.

[30]  I. Harada,et al.  Raman and ultraviolet resonance Raman spectra of proteins and related compounds , 1986 .

[31]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[32]  W. Zimmermann,et al.  Function of the Outer Membrane of Escherichia coli as a Permeability Barrier to Beta-Lactam Antibiotics , 1977, Antimicrobial Agents and Chemotherapy.

[33]  W. Zimmermann.  Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain , 1980, Antimicrobial Agents and Chemotherapy.

[34]  R. Bonomo,et al.  Understanding Resistance to β-Lactams and β-Lactamase Inhibitors in the SHV β-Lactamase , 2003, Journal of Biological Chemistry.

[35]  N. Nanninga,et al.  On the role of the high molecular weight penicillin-binding proteins in the cell cycle of Escherichia coli. , 1991, Research in microbiology.

[36]  P. Carey,et al.  Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence. , 2009, Journal of the American Chemical Society.

[37]  W. Zimmermann,et al.  Binding of Thienamycin and Clavulanic Acid to the Penicillin-Binding Proteins of Escherichia coli K-12 , 1977, Antimicrobial Agents and Chemotherapy.

[38]  L. Rice,et al.  High-Level Expression of Chromosomally Encoded SHV-1 β-Lactamase and an Outer Membrane Protein Change Confer Resistance to Ceftazidime and Piperacillin- Tazobactam in a Clinical Isolate of Klebsiella pneumoniae , 2000, Antimicrobial Agents and Chemotherapy.

[39]  G. Thomas.  Raman spectroscopy of protein and nucleic acid assemblies. , 1999, Annual review of biophysics and biomolecular structure.